Literature DB >> 28425223

Three families with mild PMM2-CDG and normal cognitive development.

Mari-Anne Vals1,2,3, Eva Morava4,5, Kai Teeäär6, Riina Zordania1, Sander Pajusalu1,2, Dirk J Lefeber7, Katrin Õunap1,2.   

Abstract

Congenital disorders of glycosylation (CDG) are caused by defective glycosylation of proteins and lipids. PMM2-CDG is the most common subtype among the CDG. The severity of PMM2-CDG is variable. Patients often have a recognizable phenotype with neurological and multisystem symptoms that might cause early death. We report six patients from three families who are diagnosed with a clinically mild PMM2-CDG and have normal cognitive development. All these patients had delayed gross motor skills with mild-to-moderate neurological findings. Cerebellar hypoplasia was detected in all siblings for whom brain MRI was performed. In 5/6 children the Wechsler Intelligence Scale for Children (WISC) showed normal cognitive development with full scale IQ scores ranging from borderline to average. Four patients were diagnosed with PMM2-CDG at the age of 8 years or later as their neurological symptoms were quite mild and they had been able to participate in regular school programs. We report patients with p.Val231Met/p.Arg239Trp and p.Ile120Thr/p.Gly228Cys genotypes which may cause milder variants of PMM2-CDG.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  PMM2-CDG; cerebellar hypoplasia; congenital disorders of glycosylation; mild phenotype

Mesh:

Substances:

Year:  2017        PMID: 28425223      PMCID: PMC5444958          DOI: 10.1002/ajmg.a.38235

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Congenital disorder of glycosylation type Ia: benign clinical course in a new genetic variant.

Authors:  Irina Mader; Marion Döbler-Neumann; Wilhelm Küker; Helena Stibler; Ingeborg Krägeloh-Mann
Journal:  Childs Nerv Syst       Date:  2001-09-22       Impact factor: 1.475

2.  A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.

Authors:  Rita Barone; M Carrozzi; R Parini; R Battini; D Martinelli; M Elia; M Spada; F Lilliu; G Ciana; A Burlina; V Leuzzi; M Leoni; L Sturiale; G Matthijs; J Jaeken; M Di Rocco; D Garozzo; A Fiumara
Journal:  J Neurol       Date:  2014-10-30       Impact factor: 4.849

3.  Thyroid function in PMM2-CDG: diagnostic approach and proposed management.

Authors:  Miski Mohamed; Miranda Theodore; Hedi Claahsen-van der Grinten; Antonius E van Herwaarden; Karin Huijben; Lotte van Dongen; Dorus Kouwenberg; Dirk J Lefeber; Ron A Wevers; Eva Morava
Journal:  Mol Genet Metab       Date:  2012-02-13       Impact factor: 4.797

Review 4.  Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders.

Authors:  B A Hagberg; G Blennow; B Kristiansson; H Stibler
Journal:  Pediatr Neurol       Date:  1993 Jul-Aug       Impact factor: 3.372

5.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Authors:  G Matthijs; E Schollen; C Bjursell; A Erlandson; H Freeze; F Imtiaz; S Kjaergaard; T Martinsson; M Schwartz; N Seta; S Vuillaumier-Barrot; V Westphal; B Winchester
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

Review 6.  Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).

Authors:  G Matthijs; E Schollen; L Heykants; S Grünewald
Journal:  Mol Genet Metab       Date:  1999-10       Impact factor: 4.797

7.  Thrombotic complications in patients with PMM2-CDG.

Authors:  M Linssen; M Mohamed; R A Wevers; D J Lefeber; E Morava
Journal:  Mol Genet Metab       Date:  2013-02-16       Impact factor: 4.797

8.  Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  E Van Schaftingen; J Jaeken
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

9.  Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening.

Authors:  S Vermeer; H P H Kremer; Q H Leijten; H Scheffer; G Matthijs; R A Wevers; N A V M Knoers; E Morava; D J Lefeber
Journal:  J Neurol       Date:  2007-08-15       Impact factor: 4.849

10.  Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.

Authors:  Harald Stefanits; Vassiliki Konstantopoulou; Magnus Kuess; Ivan Milenkovic; Christian Matula
Journal:  J Neurosurg Pediatr       Date:  2014-09-05       Impact factor: 2.375

View more
  9 in total

1.  The Prevalence of PMM2-CDG in Estonia Based on Population Carrier Frequencies and Diagnosed Patients.

Authors:  Mari-Anne Vals; Sander Pajusalu; Mart Kals; Reedik Mägi; Katrin Õunap
Journal:  JIMD Rep       Date:  2017-07-07

2.  Neurological Consequences of Congenital Disorders of Glycosylation.

Authors:  Justyna Paprocka
Journal:  Adv Neurobiol       Date:  2023

Review 3.  Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review.

Authors:  Majid Alfadhel; Amir Babiker
Journal:  Sudan J Paediatr       Date:  2018

4.  Cystic kidney diseases associated with mutations in phosphomannomutase 2 promotor: a large spectrum of phenotypes.

Authors:  Guillaume Dorval; Cécile Jeanpierre; Vincent Morinière; Carole Tournant; Bettina Bessières; Tania Attié-Bittach; Jeanne Amiel; Emmanuel Spaggari; Yves Ville; Elodie Merieau; Marie-Claire Gubler; Sophie Saunier; Laurence Heidet
Journal:  Pediatr Nephrol       Date:  2021-02-13       Impact factor: 3.714

5.  N-Glycosylation influences human corticosteroid-binding globulin measurements.

Authors:  Lesley A Hill; Zeynep Sumer-Bayraktar; John G Lewis; Eva Morava; Morten Thaysen-Andersen; Geoffrey L Hammond
Journal:  Endocr Connect       Date:  2019-08       Impact factor: 3.335

6.  Clinical and whole-exome sequencing findings in two siblings from Hani ethnic minority with congenital glycosylation disorders.

Authors:  Zhen Zhang; Ti-Long Huang; Jing Ma; Wen-Ji He; Huaiyu Gu
Journal:  BMC Med Genet       Date:  2019-11-14       Impact factor: 2.103

Review 7.  Congenital Disorders of Glycosylation from a Neurological Perspective.

Authors:  Justyna Paprocka; Aleksandra Jezela-Stanek; Anna Tylki-Szymańska; Stephanie Grunewald
Journal:  Brain Sci       Date:  2021-01-11

8.  Genotype-Phenotype Correlations in PMM2-CDG.

Authors:  Laurien Vaes; Daisy Rymen; David Cassiman; Anna Ligezka; Nele Vanhoutvin; Dulce Quelhas; Eva Morava; Peter Witters
Journal:  Genes (Basel)       Date:  2021-10-21       Impact factor: 4.096

9.  Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG).

Authors:  Fabio Pettinato; Giovanni Mostile; Roberta Battini; Diego Martinelli; Annalisa Madeo; Elisa Biamino; Daniele Frattini; Domenico Garozzo; Serena Gasperini; Rossella Parini; Fabio Sirchia; Giuseppe Sortino; Luisa Sturiale; Gert Matthijs; Amelia Morrone; Maja Di Rocco; Renata Rizzo; Jaak Jaeken; Agata Fiumara; Rita Barone
Journal:  Cerebellum       Date:  2021-02-22       Impact factor: 3.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.